NFE2L2 participates in hepatic fatty acid metabolism as a negative moderator of genes that promote hepatic lipogenesis, thus mediating crosstalk between antioxidant responses and lipid metabolism in NAFLD [28]. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.